Drug General Information
Drug ID
D0B3LP
Former ID
DNC014737
Drug Name
Ro-16-6028
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Discontinued in Phase 3 [467491], [544696]
Formula
C19H20BrN3O3
InChI
InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1
InChIKey
LWUDDYHYYNNIQI-ZDUSSCGKSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 467491(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4146).
Ref 544696Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000640)